Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-017340)

Filing Details

Accession Number:: 0001209191-14-017340
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-03-05 16:20:51
Reporting Period:: 2014-03-03

Filing Date:: 2014-03-05
Accepted Time:: 2014-03-05 16:20:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
816284	Celgene Corp	CELG	Pharmaceutical Preparations (2834)	222711928

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1260573	A Perry Karsen	C/O Celgene Corporation 86 Morris Avenue Summit NJ 07901	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-03-03	2,408	$159.05	25,960	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,000	Indirect	IRA Account
Common Stock	614	Indirect	401(k) Plan

Footnotes

These shares were sold pursuant to the reporting person's existing Rule 10b5-1 plan.